Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Wadie Bahou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 36 Finished
-
Molecular characterization of biliverdin IXbeta reductase
Bahou, W. (PI) & Zhu, W. (CoI)
National Heart Lung and Blood Institute
07/1/21 → 03/31/26
Project: Research
-
A Structure-guided Active Site Affinity Ligand Unmasks a Stress-Sensitizing Role for BLVRB in the Endoplasmic Reticulum
Thekke Veedu, R. R., Sheriff, J., Nesbitt, N. M., Marchenko, N., Pennacchia, L., Ginex, T., Hearing, P., Kreitler, D. F. & Bahou, W. F., Aug 27 2026, In: Journal of Medicinal Chemistry. 69, 16, p. 19933-19950 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Case report: Heparin coagulant super-sensitivity during leech therapy
Rong, Z., Daniels, A., Luu, K., Czerwonka, L. & Bahou, W. F., Dec 2026, In: Thrombosis Journal. 24, 1, 58.Research output: Contribution to journal › Article › peer-review
Open Access -
Biliverdin reductase B as a new target in breast cancer
Marchenko, N., Nesbitt, N. M., Alexandrova, E., Reisz, J. A., D’Alessandro, A., Suh, J., Uryasev, S., Pennacchia, L. & Bahou, W. F., Dec 2025, In: Breast Cancer Research. 27, 1, 179.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo
Nesbitt, N. M., Araldi, G. L., Pennacchia, L., Marchenko, N., Assar, Z., Muzzarelli, K. M., Thekke Veedu, R. R., Medel-Lacruz, B., Lee, E., Eisenmesser, E. Z., Kreitler, D. F. & Bahou, W. F., Dec 2025, In: Nature Communications. 16, 1, 3480.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
ACTIV-4C Study Group, Apr 2023, In: Annals of Internal Medicine. 176, 4, p. 515-523 9 p.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations